Stockreport

Achieve Life Sciences Announces Completion of Enrollment in 254-Subject Phase 2b Trial of Cytisinicline for Smoking Cessation

Achieve Life Sciences, Inc. - Common Shares  (ACHV) 
Last achieve life sciences, inc. - common shares earnings: 3/13 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.achievelifesciences.com